{
    "clinical_study": {
        "@rank": "20053", 
        "arm_group": {
            "arm_group_label": "KPS-0373", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the long-term safety, efficacy, and\n      pharmacokinetics of KPS-0373 in SCD patients."
        }, 
        "brief_title": "An Extension Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)", 
        "condition": "Spinocerebellar Degeneration", 
        "condition_browse": {
            "mesh_term": [
                "Spinocerebellar Degenerations", 
                "Spinocerebellar Ataxias"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Japanese SCD patients with mild to moderate ataxia (Completion of the KPS1301 study)\n\n        Exclusion Criteria:\n\n          -  Less than 75% of compliance in KPS1301 study"
            }, 
            "gender": "Both", 
            "maximum_age": "N/A", 
            "minimum_age": "20 Years"
        }, 
        "firstreceived_date": "October 22, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01970111", 
            "org_study_id": "KPS1302"
        }, 
        "intervention": [
            {
                "arm_group_label": "KPS-0373", 
                "intervention_name": "KPS-0373, High dose", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "KPS-0373", 
                "intervention_name": "KPS-0373, Low dose", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Thyrotropin-Releasing Hormone"
        }, 
        "keyword": [
            "Spinocerebellar degeneration (SCD)", 
            "Thyrotropin-Releasing Hormone (TRH)", 
            "Spinocerebellar Ataxia (SCA)", 
            "Cortical Cerebellar Atrophy (CCA)"
        ], 
        "lastchanged_date": "October 22, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Tokyo and Other Japanese Cities", 
                    "country": "Japan"
                }
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Japan"
        }, 
        "overall_contact": {
            "email": "rinsyousiken@pharm.kissei.co.jp", 
            "last_name": "Kissei Pharmaceutical Co., Ltd"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Japan: Ministry of Health, Labor and Welfare"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "SARA (Scale for the Assessment and Rating of Ataxia)", 
            "safety_issue": "No", 
            "time_frame": "52 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01970111"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "SF-8 (QOL)", 
            "safety_issue": "No", 
            "time_frame": "52 weeks"
        }, 
        "source": "Kissei Pharmaceutical Co., Ltd.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Kissei Pharmaceutical Co., Ltd.", 
                "agency_class": "Industry"
            }
        }, 
        "study_design": "N/A", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}